home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

New Player In Inflammatory 'Shutdown'

 
  May, 2 2007 21:41
your information resource in human molecular genetics
 
     
Scientists show that a protein within immune cells stands poised to dampen inflammation, according to an article published online in Nature Immunology.

Inflammatory proteins are produced by immune cells following microbial infection. After clearance of the invading pathogen the inflammatory response must be switched off to avoid excessive damage to host tissues.

Tsuneyaso Kaisho and colleagues now demonstrate that a protein called PDLIM2 continuously targets the p65 subunit of the proinflammatory transcription factor NF-kB for destruction. PDLIM2 marks p65 for degradation and routes p65 into cellular compartments containing demolition machinery.

Consequently, mice lacking PDLIM2 suffer from lethal uncontrolled inflammation. These findings pinpoint another potential target for therapeutic efforts to suppress excessive inflammatory responses.

Author contact:

Tsuneyasho Kaisho (RIKEN Research Center for Allergy and Immunology, Kanagawa, Japan)
E-mail: tkaisho@rcai.riken.jp

Abstract available online.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.